COGT - Cogent Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$46.75
DETAILS
HIGH:
$55.00
LOW:
$35.00
MEDIAN:
$48.50
CONSENSUS:
$46.75
UPSIDE:
24.35%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 14.23 |
| Quick Ratio | 14.23 |
| Solvency Ratio | -1.077 |
| Cash Ratio | 4.88 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-13.93
Peers avg: 56.4
|
| PEG Ratio | -3.81 |
| Forward PEG | -3.81 |
| Price/Book | 3.77 |
| Price/Sales | 0.00 |
| Price/FCF | -9.03 |
| Price/Op Cash Flow | -9.08 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.2700 |
| Debt/Equity | 0.3978 |
| Debt/Capital | 0.2846 |
| Long-Term Debt/Capital | 0.2716 |
| Financial Leverage | 1.47 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -4.135 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -69.70 |
| Interest Coverage | -108.8710 |
| Short-Term Operating Cash Flow Coverage | -170.94 |
| Operating Cash Flow Coverage | -1.04 |
| Capital Expenditure Coverage | -170.17 |
| Dividend + Capital Expenditure Coverage | -170.17 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -4.866 |
| Debt/Share | 3.7901 |
| Cash/Share | 13.32 |
| Book Value/Share | 9.41 |
| Tangible BV/Share | 9.41 |
| Equity/Share | 9.41 |
| Operating Cash Flow/Share | -3.912 |
| Capital Expenditure/Share | 0.023 |
| FCF/Share | -3.935 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.987 |
| Price/Fair Value | 3.77 |
| Debt/Market Cap | 0.0995 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -7.29 |